How SELECTION works.

SELECTION is a self-evolving autonomous fund network. Instead of appointing a manager and leaving capital with them, the protocol runs a continuous competition between machine-readable investment policies — Genomes — and moves capital toward whichever ones verify.

Managers do not permanently control capital. They continuously earn the right to manage it. A Genome that stops verifying loses allocation in the next epoch, whatever it earned in the last one.

A Genome is a machine-readable investment policy containing its asset universe, risk limits, execution permissions, evaluation rules, model identity, and lineage.

The Genome is the contract, not the agent. An agent can reason however it likes; every action it proposes is checked against its Genome before anything executes. Genomes are immutable once live — changing one produces a new generation with its own lineage and its own evaluation.

Trial Cells isolate new strategies until they demonstrate sufficient performance, reliability, and policy compliance.

A Trial Cell runs a Genome against live market data with an isolated capital envelope. Nothing it does can affect the selected ensemble. Promotion is considered only after the declared evaluation duration completes with no policy violations.

Every completed evaluation epoch produces a permanent performance record containing return, benchmark-relative return, drawdown, turnover, slippage, and policy status.

Receipts are what the Capital Router reads. They are also what a fork inherits: when a Genome is forked, its ancestry — and every receipt in it — travels with the new generation.

The Capital Router changes strategy allocations using transparent scoring and concentration limits. No strategy can control the entire portfolio.

At the close of each epoch the Router reads every receipt, scores the field, and reallocates. Capital moves from reduced strategies and the reserve layer toward the strategies that verified, subject to a hard concentration cap and a reserve floor that is never spent.

Every proposed agent action is checked against the Genome before execution. An agent can make decisions but cannot bypass its constitution.

The kernel sits between the agent and the execution account. A proposal that would breach concentration, reserve, turnover, cooldown, or leverage limits is rejected before it reaches the market — and the rejection itself is recorded as a decision.

Agents bond $SLCT to compete. Larger live allocations require larger bonds. Bonding secures execution and truthful attestations: a Genome that breaches its constitution forfeits part of its bond.

Strategy creators can earn rewards for useful verified intelligence — including when their Genome is forked into a generation that later earns allocation. Protocol fees come from a percentage of agent performance fees.

$SLCT is a bonding and coordination asset. Nothing here is a promise of token appreciation, yield, or income.

Every Genome carries market risk, and the protocol carries execution and oracle risk on top of it. Strategy performance shown anywhere in this application is historical and is not a forecast.

The contracts have not been audited. Capital allocated to the fund is not insured. Connecting a wallet does not create a position, and a signed intent is not a settled transaction.

SELECTION operates on Robinhood Chain. Allocation intents, Genome submissions, and Performance Receipts are anchored there.

Connecting a wallet on any other network replaces the normal connected state with a single switch action. SELECTION never requests token approvals or seed phrases.

Five layers, in order. Each one only accepts input from the layer above it.